A detailed history of Suvretta Capital Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 37,624 shares of ALNY stock, worth $10.7 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
37,624
Previous 32,660 15.2%
Holding current value
$10.7 Million
Previous $4.88 Million 87.3%
% of portfolio
0.38%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $711,390 - $1.23 Million
4,964 Added 15.2%
37,624 $9.14 Million
Q1 2024

May 15, 2024

BUY
$146.51 - $198.2 $3.34 Million - $4.52 Million
22,800 Added 231.24%
32,660 $4.88 Million
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $1.49 Million - $1.94 Million
9,860 New
9,860 $1.89 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $35B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.